Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2015-08-17 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 98% confidence The document text is a formal announcement, written in Danish, detailing transactions related to Novozymes' share repurchase program ('aktietilbagekøbsprogram'). It specifically reports the number of shares bought back, the transaction value, and references a previous company announcement (nr. 6, 2015) and regulatory framework (Safe Harbour Regulation). This content directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a direct report of the activity, not an announcement of a report's publication.
2015-08-17 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company managing its own shares, which corresponds to the 'Transaction in Own Shares' definition. The length is very short (288 chars) and it directs the user to read the full announcement in PDF format, suggesting it is an announcement of the transaction rather than the detailed regulatory filing itself. However, the core subject matter is the share transaction, making 'POS' the most specific fit over the general 'RPA' or 'RNS'.
2015-08-10 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 98% confidence The document explicitly details transactions made under a 'stock buyback program,' reporting the number of shares purchased, the average price, and the total transaction value over several days (August 3 to August 7, 2015). This directly relates to the company acquiring its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document is a specific report on this activity, not an announcement of a report (RPA) or a general regulatory filing (RNS).
2015-08-10 English
Interim / Quarterly Report 2015
Interim / Quarterly Report
2015-08-06 Danish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Novozymes A/S for the first half of 2015. It contains detailed financial statements, performance analysis, segment reporting, and management commentary on financial results. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis for a period shorter than a full fiscal year. H1 2015
2015-08-06 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (265 characters) and written in Danish. It explicitly states that Novozymes has bought back a total of 3,711,047 shares under a share repurchase program announced previously (selskabsmeddelelse nr. 6, 2015, started Feb 2, 2015). The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), strongly suggests this is a brief announcement about a transaction rather than the full regulatory filing detailing the transaction. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs. Since the text describes the execution of a buyback, POS is the most specific fit, although the short length and reference to a PDF could suggest RPA/RNS. Given the specific content (share repurchase execution), POS is prioritized over the general RPA/RNS.
2015-08-03 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.